Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Horwitz

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Annals of Emergency Medicine|September 10, 2014
Lack of coagulopathy after copperhead snakebitesAnah J Ali, David A Horwitz, Michael E Mullins
Arthritis Research|July 11, 2002
The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseasesDavid A Horwitz, J Dixon Gray, Song Guo Zheng
Rheumatology and Immunology Research|December 5, 2022
Nanoparticle-mediated Delivery of IL-2 To T Follicular Helper Cells Protects BDF1 Mice from Lupus-like DiseaseConcetta Ferretti, David A Horwitz, Sean Bickerton, et al.
Frontiers in Immunology|June 14, 2021
Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4<sup>+</sup> and CD8<sup>+</sup> Tregs That Are Functional in Humanized MiceSophia Giang, David A Horwitz, Sean Bickerton, et al.
European Journal of Immunology|April 9, 2008
Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ TregDavid A Horwitz, Song Guo Zheng, Juhua Wang, et al.
Trends in Immunology|October 12, 2019
Rebalancing Immune Homeostasis to Treat Autoimmune DiseasesDavid A Horwitz, Tarek M Fahmy, Ciriaco A Piccirillo, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|May 29, 2012
Emergency department patients with diabetes have better glycemic control when they have identifiable primary care providersDavid A Horwitz, Evan S Schwarz, Mitchell G Scott, et al.
Plos One|December 24, 2010
Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acidLing Lu, Xiaohui Zhou, Julie Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cellsSong Guo Zheng, Juhua Wang, Pu Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2018
Suppression of Murine Lupus by CD4+ and CD8+ Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor βDavid A Horwitz, Sean Bickerton, Michael Koss, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Annals of Emergency Medicine|September 10, 2014
Lack of coagulopathy after copperhead snakebitesAnah J Ali, David A Horwitz, Michael E Mullins
Arthritis Research|July 11, 2002
The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseasesDavid A Horwitz, J Dixon Gray, Song Guo Zheng
Rheumatology and Immunology Research|December 5, 2022
Nanoparticle-mediated Delivery of IL-2 To T Follicular Helper Cells Protects BDF1 Mice from Lupus-like DiseaseConcetta Ferretti, David A Horwitz, Sean Bickerton, et al.
Frontiers in Immunology|June 14, 2021
Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4<sup>+</sup> and CD8<sup>+</sup> Tregs That Are Functional in Humanized MiceSophia Giang, David A Horwitz, Sean Bickerton, et al.
European Journal of Immunology|April 9, 2008
Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ TregDavid A Horwitz, Song Guo Zheng, Juhua Wang, et al.
Trends in Immunology|October 12, 2019
Rebalancing Immune Homeostasis to Treat Autoimmune DiseasesDavid A Horwitz, Tarek M Fahmy, Ciriaco A Piccirillo, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|May 29, 2012
Emergency department patients with diabetes have better glycemic control when they have identifiable primary care providersDavid A Horwitz, Evan S Schwarz, Mitchell G Scott, et al.
Plos One|December 24, 2010
Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acidLing Lu, Xiaohui Zhou, Julie Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cellsSong Guo Zheng, Juhua Wang, Pu Wang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2018
Suppression of Murine Lupus by CD4+ and CD8+ Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor βDavid A Horwitz, Sean Bickerton, Michael Koss, et al.
Pageof 4